Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Breast Neoplasms drug therapy"" wg kryterium: Temat


Tytuł :
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Autorzy :
Murthy, R. K.
Loi, S.
Okines, A.
Paplomata, E.
Hamilton, E.
Hurvitz, S. A.
Lin, N. U.
Borges, V.
Abramson, V.
Anders, C.
Bedard, P. L.
Oliveira, M.
Jakobsen, E.
Bachelot, T.
Shachar, S. S.
Muller, V.
Braga, S.
Duhoux, F. P.
Greil, R.
Cameron, D.
Carey, L. A.
Curigliano, G.
Gelmon, K.
Hortobagyi, G.
Krop, I.
Loibl, S.
Pegram, M.
Slamon, D.
Palanca-Wessels, M. C.
Walker, L.
Feng, W.
Winer, E. P.
Pokaż więcej
Temat :
Aged
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Brain Neoplasms/secondary
Breast Neoplasms/drug therapy
Capecitabine/administration & dosage
Consolidation Chemotherapy
Diarrhea/chemically induced
Double-Blind Method
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Progression-Free Survival
Protein-Tyrosine Kinases/antagonists & inhibitors
Receptor, ErbB-2/analysis
Trastuzumab/administration & dosage
Źródło :
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
Tytuł :
Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
Autorzy :
Ottestad, Lars
Fronth, Line
Rajendiran, Sajitha
Hege Aksnes, Liv
Eikesdal, Hans Petter
Støre Blix, Egil
Ewertz, Marianne
Pokaż więcej
Temat :
Aged
Aged, 80 and over
Androstadienes/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Breast Neoplasms/drug therapy
Everolimus/administration & dosage
Female
Follow-Up Studies
Humans
Middle Aged
Postmenopause
Prognosis
Receptor, ErbB-2/metabolism
Receptors, Estrogen/metabolism
Receptors, Progesterone/metabolism
Survival Rate
Źródło :
Ottestad, L, Fronth, L, Rajendiran, S, Hege Aksnes, L, Eikesdal, H P, Støre Blix, E & Ewertz, M 2019, ' Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ', Acta Oncologica, vol. 58, no. 3, pp. 385-387 . https://doi.org/10.1080/0284186X.2019.1566771
Opis pliku :
application/pdf
Tytuł :
Treatment of advanced HR+/HER2− breast cancer with new targeted agents in combination with endocrine therapy:a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib
Autorzy :
Bøttcher, Tea M.
Cold, Søren
Jensen, Anders B.
Pokaż więcej
Temat :
Aminopyridines/administration & dosage
Antineoplastic Agents, Hormonal/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Benzimidazoles/administration & dosage
Breast Neoplasms/drug therapy
Disease Progression
Drugs, Investigational/therapeutic use
Everolimus/administration & dosage
Female
Humans
Molecular Targeted Therapy/methods
Piperazines/administration & dosage
Purines/administration & dosage
Pyridines/administration & dosage
Randomized Controlled Trials as Topic/statistics & numerical data
Receptor, ErbB-2/genetics
Receptors, Cytoplasmic and Nuclear/genetics
Treatment Outcome
Źródło :
Bøttcher, T M, Cold, S & Jensen, A B 2019, ' Treatment of advanced HR+/HER2− breast cancer with new targeted agents in combination with endocrine therapy : a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib ', Acta Oncologica, vol. 58, no. 2, pp. 147-153 . https://doi.org/10.1080/0284186X.2018.1532603
Tytuł :
Uloga inhibitora CDK4/6 u liječenju hormonski ovisnoga metastatskog raka dojke negativnog na HER-2
Role of CDK4/6 inhibitors in metastatic hormon positive HER2 negative breast cancer treatment
Autorzy :
Ban, Marija
Strikić, Ante
Petrić Miše, Branka
Vrdoljak, Eduard
Pokaż więcej
Temat :
TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost
HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost
PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena
RECEPTOR ERBB-2 – metabolizam
CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam
CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam
AROMATOZNI INHIBITORI – terapijska primjena
FULVESTRANT – terapijska primjena
INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena
TUMORSKE METASTAZE
PREŽIVLJENJE BEZ PROGRESIJE BOLESTI
BREAST NEOPLASMSdrug therapy, metabolism, mortality, pathology
NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology
ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use
RECEPTOR, ERBB-2 – metabolism
CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism
CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism
AROMATOZNI INHIBITORI – therapeutic use
FULVESTRANT – therapeutic use
PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use
NEOPLASM METASTASIS
PROGRESSION-FREE SURVIVAL
Źródło :
Liječnički vjesnik. 141
Opis pliku :
application/pdf
Tytuł :
Effets osseux des traitements de bisphosphonates et dénosumab en cas de cancer du sein ou de la prostate
Autorzy :
Biver, Emmanuel
Pokaż więcej
Temat :
ddc:616
Androgen Antagonists/therapeutic use
Bone Density
Bone Density Conservation Agents/therapeutic use
Bone Neoplasms/drug therapy/secondary
Breast Neoplasms/drug therapy
Denosumab/therapeutic use
Diphosphonates
Female
Humans
Male
Neoplasm Recurrence
Local
Prostatic Neoplasms/drug therapy
Źródło :
Revue médicale suisse, Vol. 15, No 647 (2019) pp. 824-830
Tytuł :
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
Autorzy :
Buhl, Anna Sofie Kappel
Christensen, Troels Dreier
Christensen, Ib Jarle
Nelausen, Knud Mejer
Balslev, Eva
Knoop, Ann Søegaard
Brix, Eva Harder
Svensson, Else
Glavicic, Vesna
Luczak, Adam
Langkjer, Sven Tyge
Linnet, Søren
Jakobsen, Erik Hugger
Bogovic, Jurij
Ejlertsen, Bent
Rasmussen, Annie
Hansen, Anker
Knudsen, Steen
Nielsen, Dorte
Jensen, Peter Buhl
Pokaż więcej
Temat :
Retrospective Studies
Clinical Trial
Aged
RNA, Messenger/genetics
Epirubicin
Gene Expression Regulation, Neoplastic/drug effects
Breast Neoplasms/drug therapy
Disease Progression
Middle Aged
Epirubicin/administration & dosage
Biomarkers, Pharmacological
Disease-Free Survival
Prospective Studies
Precision medicine
Journal Article
Predictive biomarker
Advanced breast cancer
Adult
Female
Humans
Neoplasm Proteins/genetics
Proportional Hazards Models
Źródło :
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ' Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391-400 . https://doi.org/10.1007/s10549-018-4918-4
Breast Cancer Research and Treatment
Opis pliku :
application/pdf
Tytuł :
Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities – Systematic Review
Terapia Antiplaquetária em Pacientes com Câncer de Mama em Uso de Terapia Hormonal: Mitos, Evidências e Potencialidades – Revisão Sistemática
Autorzy :
Leite, Andréa de Melo
Macedo, Ariane Vieira Scarlatelli
Jorge, Antonio José Lagoeiro
Martins, Wolney de Andrade
Pokaż więcej
Temat :
Breast Neoplasms/drug therapy
Indicators of Morbidity and Mortality
Aspirin
Tamoxifen
Raloxilene Hydrochloride
Cardiovascular Diseases/prevention & control
Selective Estrogen Receptor Modulators
Neoplasias da Mama/tratamento farmacológico
Indicadores de Morbimortalidade
Aspirina
Tamoxifeno
Cloridrato de Raloxifeno
Doenças Cardiovasculares/prevenção & controle
Moduladores Seletivos do Receptor Estrogênio
Źródło :
Arquivos Brasileiros de Cardiologia, Volume: 111, Issue: 2, Pages: 205-212, Published: AUG 2018
Opis pliku :
text/html
Tytuł :
SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer
Autorzy :
Alves, Carla L.
Ditzel, Henrik J.
Elias, Daniel
Lyng, Maria B.
Bak, Martin
Pokaż więcej
Temat :
Research Article
Estrogen receptor-positive breast cancer
Endocrine resistance
Fulvestrant
Drug Resistance, Neoplasm/genetics
SNAI2
Aged
Gene Expression Regulation, Neoplastic/genetics
Middle Aged
Breast Neoplasms/drug therapy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Antineoplastic Agents, Hormonal/administration & dosage
Epithelial-Mesenchymal Transition/drug effects
Snail Family Transcription Factors/genetics
RC254-282
Neoplasm Metastasis
Fulvestrant/administration & dosage
Epithelial-mesenchymal transition
Adult
Female
Humans
Estrogen Receptor alpha/genetics
MCF-7 Cells
Cell Proliferation/drug effects
Źródło :
Breast Cancer Research : BCR
Breast Cancer Research, Vol 20, Iss 1, Pp 1-12 (2018)
Alves, C M L, Elias, D, Lyng, M B, Bak, M & Ditzel, H 2018, ' SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer ', Breast Cancer Research, vol. 20, 60 . https://doi.org/10.1186/s13058-018-0988-9
Opis pliku :
application/pdf
Tytuł :
Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
Acurácia do Strain Longitudinal Global na Predição de Cardiotoxicidade em uma Coorte de Pacientes com Câncer de Mama em Tratamento com Antracíclicos e/ou Trastuzumab
Autorzy :
Gripp, Eliza de Almeida
Oliveira, Gabriela Escudini de
Feijó, Luiz Augusto
Garcia, Marcelo Iorio
Xavier, Sergio Salles
Sousa, Andréa Silvestre de
Pokaż więcej
Temat :
Breast Neoplasms/drug therapy
Cardiotoxicity
Stroke Volume
Trastuzumab
Indicators of Morbidity and Mortality
Neoplasias da Mama/tratamento farmacológico
Cardiotoxicidade
Volume Sistólico
Trastuzumab, Indicadores de Morbimortalidade
Źródło :
Arquivos Brasileiros de Cardiologia, Volume: 110, Issue: 2, Pages: 140-150, Published: FEB 2018
Opis pliku :
text/html
Tytuł :
Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
Autorzy :
Gripp, Eliza de Almeida
de Oliveira, Gabriela Escudini
Feijó, Luiz Augusto
Garcia, Marcelo Iorio
Xavier, Sergio Salles
de Sousa, Andréa Silvestre
Pokaż więcej
Temat :
RC666-701
Indicators of Morbidity and Mortality
Trastuzumab, Indicadores de Morbimortalidade
Diseases of the circulatory (Cardiovascular) system
Breast Neoplasms/drug therapy
Stroke Volume
Trastuzumab
Cardiotoxicity
Neoplasias da Mama/tratamento farmacológico
Volume Sistólico
Original Articles
Echocardiography - Adults
Cardiotoxicidade
Źródło :
Arquivos Brasileiros de Cardiologia, Vol 110, Iss 2, Pp 140-150
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.110 n.2 2018
Opis pliku :
text/html
Tytuł :
Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
Autorzy :
Gripp, Eliza de Almeida
Oliveira, Gabriela Escudini de
Feijó, Luiz Augusto
Garcia, Marcelo Iorio
Salles Xavier, Sergio
Sousa, Andréa Silvestre de
Pokaż więcej
Temat :
Cardiology
Breast Neoplasms/drug therapy
Cardiotoxicity
Stroke Volume
Trastuzumab
Indicators of Morbidity and Mortality

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies